Alimera Sciences reported $9.86M in Selling and Administration Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US USD 3.22B 86M
Alimera Sciences ALIM:US USD 9.86M 46K
Bayer BAYN:GR EUR 4.08B 393M
Insmed INSM:US USD 75.58M 15.61M
Novartis NOVN:VX USD 3.4B 185M
Ophthotech OPHT:US USD 17.54M 1.44M
Regeneron Pharmaceuticals REGN:US USD 529.1M 52.8M
Roche Holding ROG:VX 5.64B 899M